{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:16:45Z","timestamp":1789690605196,"version":"4.0.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1093\/europace\/euag142","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:48:27Z","timestamp":1781092107000},"source":"Crossref","is-referenced-by-count":0,"title":["Amiodarone dose to treat ventricular tachycardia in Chagas cardiomyopathy"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-6555","authenticated-orcid":false,"given":"Henrique Horta","family":"Veloso","sequence":"first","affiliation":[{"name":"Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation , Avenida Brasil, 4.365, Rio de Janeiro, RJ 21040-360 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-3631","authenticated-orcid":false,"given":"Mauro Felippe Felix","family":"Mediano","sequence":"additional","affiliation":[{"name":"Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation , Avenida Brasil, 4.365, Rio de Janeiro, RJ 21040-360 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026091720011334500_euag142-B1","doi-asserted-by":"crossref","first-page":"euaf311","DOI":"10.1093\/europace\/euaf311","article-title":"Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis","volume":"27","author":"Silva","year":"2025","journal-title":"Europace"},{"key":"2026091720011334500_euag142-B2","doi-asserted-by":"crossref","first-page":"euaf076","DOI":"10.1093\/europace\/euaf076","article-title":"Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European heart rhythm association of the European Society of Cardiology","volume":"27","author":"Merino","year":"2025","journal-title":"Europace"},{"key":"2026091720011334500_euag142-B3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006742","article-title":"Amiodarone for arrhythmia in patients with Chagas disease: a systematic review and individual patient data meta-analysis","volume":"12","author":"Stein","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2026091720011334500_euag142-B4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-8703(84)90311-9","article-title":"Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis","volume":"107","author":"Chiale","year":"1984","journal-title":"Am Heart J"},{"key":"2026091720011334500_euag142-B5","first-page":"367","article-title":"Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia","volume":"54","author":"Scanavacca","year":"1990","journal-title":"Arq Bras Cardiol"},{"key":"2026091720011334500_euag142-B6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1540-8167.2003.02278.x","article-title":"Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol","volume":"14","author":"Leite","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026091720011334500_euag142-B7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1540-8167.2007.00954.x","article-title":"Predictors of all-cause mortality for patients with chronic chagas\u2019 heart disease receiving implantable cardioverter defibrillator therapy","volume":"18","author":"Cardinalli-Neto","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026091720011334500_euag142-B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/eut422","article-title":"Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with chagas\u2019 heart disease: comparison with a control group treated with amiodarone alone","volume":"16","author":"Gali","year":"2014","journal-title":"Europace"},{"key":"2026091720011334500_euag142-B9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2012.05.040","article-title":"Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas\u2019 heart disease","volume":"110","author":"Martinelli","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026091720011334500_euag142-B10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamacardio.2024.3169","article-title":"Amiodarone or implantable cardioverter-defibrillator in Chagas cardiomyopathy: the CHAGASICS randomized clinical trial","volume":"9","author":"Martinelli-Filho","year":"2024","journal-title":"JAMA Cardiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/9\/euag142\/71186926\/euag142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/9\/euag142\/71186926\/euag142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:01:18Z","timestamp":1789689678000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag142\/8811961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag142","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"euag142"}}